Masking the transmembrane region of the amyloid β precursor protein as a safe means to lower amyloid β production
Abstract Introduction Reducing brain levels of both soluble and insoluble forms of amyloid beta (Aβ) remains the primary goal of most therapies that target Alzheimer's disease (AD). However, no treatment has so far resulted in patient benefit, and clinical trials of the most promising drug cand...
Main Authors: | Ayesha Khan, Richard Killick, Daniel Wirth, Dominique Hoogland, Kalina Hristova, Jakob P. Ulmschneider, Christopher R. King, Martin B. Ulmschneider |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-10-01
|
Series: | Alzheimer’s & Dementia: Translational Research & Clinical Interventions |
Subjects: | |
Online Access: | https://doi.org/10.1002/trc2.12428 |
Similar Items
-
Cholesterol-dependent amyloid β production: space for multifarious interactions between amyloid precursor protein, secretases, and cholesterol
by: Vladimir Rudajev, et al.
Published: (2023-09-01) -
Structural Determinant of β-Amyloid Formation: From Transmembrane Protein Dimerization to β-Amyloid Aggregates
by: Nicolas Papadopoulos, et al.
Published: (2022-10-01) -
Small GTPases control macropinocytosis of amyloid precursor protein and cleavage to amyloid-β
by: Justin Chiu, et al.
Published: (2024-05-01) -
Amyloid precursor protein : a practical approach /
by: Xia, Weiming, et al.
Published: (2005) -
Soluble amyloid-β precursor peptide does not regulate GABAB receptor activity
by: Pascal Dominic Rem, et al.
Published: (2023-01-01)